S
Stemina Biomarker Discovery
And commercializes molecular biomarkers to improve drug safety and human health
About Stemina Biomarker Discovery
Stemina Biomarker Discovery operates in the biotechnology sector, specializing in in vitro toxicity testing and neurological disorder diagnostics. The company serves pharmaceutical, food, and consumer product industries by providing highly predictive human cell-based assays that offer an alternative to traditional animal testing. Stemina's core business units include Stemina, focused on toxicology, and NeuroPointDX, which targets the diagnosis and treatment of neurological disorders such as autism. Utilizing a shared metabolomics platform, Stemina's devTOX quickPredict and Cardio quickPredict assays identify developmental and cardiotoxicity potential of drug candidates and other compounds. The business model revolves around offering these predictive assays to clients, generating revenue through service fees and long-term contracts. Stemina's innovative approach aims to improve human health by providing more accurate and ethical testing methods.
Source: Dealroom company dataNews
Open roles
Stemina Biomarker Discovery in the Madison ecosystem
The Stemina Biomarker Discovery office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series A3 investors entered at this stage
- DCDaneVest Capital
- PAPhenomenelle Angels
Wisconsin Investment Partners
Series B and later1 investor entered at this stage
Arenberg Holdings
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stemina Biomarker Discovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stemina Biomarker Discovery on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
